The current level 1 evidence does not support the routine use of oral antibiotics postoperatively.
TRIO Best Practices
The practice of discontinuing estrogen therapy for two weeks prior to surgery should be weighed against individual risk factors, mode of administration, and side effects.
Recent prospective clinical studies have not found an increased incidence of facial scarring in patients using isotretinoin in the perioperative period.
Many patients who would likely benefit from implantation are never referred due to poor regional access, and, perhaps most importantly, lack of established CIE referral guidelines.
Sterotactic radiosurgery (SRS) for the treatment of VS can be associated with increased balance symptoms, often within the first six months after treatment.
Existing evidence suggests that olfactory training is a low-risk intervention that provides clinically relevant and sustained benefit in some PISL patients.
Cost-effectiveness varies between adults and children.